Marco Zuin

ORCID: 0000-0002-4559-1292
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Venous Thromboembolism Diagnosis and Management
  • Coronary Interventions and Diagnostics
  • COVID-19 Clinical Research Studies
  • Acute Myocardial Infarction Research
  • Cardiac Imaging and Diagnostics
  • Atrial Fibrillation Management and Outcomes
  • Cardiovascular and Diving-Related Complications
  • Long-Term Effects of COVID-19
  • COVID-19 and healthcare impacts
  • Acute Ischemic Stroke Management
  • Cerebrovascular and Carotid Artery Diseases
  • Cardiac Valve Diseases and Treatments
  • Cardiac Arrhythmias and Treatments
  • Cardiac Structural Anomalies and Repair
  • Aortic aneurysm repair treatments
  • Cardiac Arrest and Resuscitation
  • Blood Pressure and Hypertension Studies
  • Coronary Artery Anomalies
  • Cardiac pacing and defibrillation studies
  • Aortic Disease and Treatment Approaches
  • Peripheral Artery Disease Management
  • Congenital Heart Disease Studies
  • Cardiovascular Disease and Adiposity
  • Cardiovascular Function and Risk Factors
  • Cardiovascular Health and Disease Prevention

University of Ferrara
2016-2025

University of Padua
2024-2025

Arcispedale Sant'Anna
2022-2025

International Renal Research Institute of Vicenza
2022-2023

Ospedale Santa Maria della Misericordia di Rovigo
2010-2023

Ospedale Sant'Anna
2021-2023

Azienda Ospedaliero Universitaria Ospedali Riuniti
2023

Fundación Juan March
2023

ERN GUARD-Heart
2023

Azienda Sanitaria Universitaria Integrata di Trieste
2023

Growing evidence has shown that high levels of lipoprotein (a) (Lp(a)) and chronic inflammation may be responsible for the residual risk cardiovascular events in patients managed with an optimal evidence-based approach. Clinical studies have demonstrated a correlation between higher Lp(a) several atherosclerotic diseases including ischemic heart disease, stroke, degenerative calcific aortic stenosis. The threshold value serum concentrations associated significantly increased is >125 nmol/L...

10.3390/jcm12072529 article EN Journal of Clinical Medicine 2023-03-27

Abstract We evaluated the effect of Acetyl-cholinesterase-inhibitors (AChEIs) on cognitive decline and overall survival in a large sample older patients with late onset Alzheimer’s disease (LOAD), vascular dementia (VD) or Lewy body (LBD) from real world setting. Patients enrolled between 2005 2020 by "Alzheimer's Disease Research Centers" were analysed; mean follow-up period was 7.9 years. A 1:1 propensity score matching performed generating cohort 1.572 (786 treated [AChEIs +] 786 not...

10.1038/s41598-022-16476-w article EN cc-by Scientific Reports 2022-07-16

To assess the sex- and age-specific trends in acute myocardial infarction (AMI) mortality modern European Union (EU-27) member states between years 2012 2020.Data on cause-specific deaths population numbers by sex for each country of EU-27 were retrieved through a publicly available Statistical Office (EUROSTAT) dataset to 2020. AMI-related ascertained when codes AMI (ICD-10 I21.0-I22.0) listed as underlying cause death medical certificate. Deaths occurring before age 65 defined premature...

10.1093/eurjpc/zwad214 article EN European Journal of Preventive Cardiology 2023-06-28
Coming Soon ...